BCI PHARMA
BCI Pharma designs and synthesizes kinase inhibitor libraries. They identify novel, potent, and selective kinase inhibitor hits. They develop cell-based assays. They also plan to deliver medications for inflammatory diseases, CNS disorders, and cancer. Their goal is to create a world-renowned firm that its patients, customers, investors, business partners, and the communities where they work and live regard highly.
BCI PHARMA
Social Links:
Industry:
Biotechnology Business Development Finance Health Care Innovation Management
Founded:
2013-01-01
Address:
Grabels, Languedoc-Roussillon, France
Country:
France
Website Url:
http://www.bci-pharma.com
Total Employee:
1+
Status:
Active
Total Funding:
3.9 M EUR
Technology used in webpage:
Google Maps ReCAPTCHA Pound Sterling ReCAPTCHA V2 French Server Location
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Investors List
TCD Capital (ex TheClubDeal)
TCD Capital (ex TheClubDeal) investment in Series A - BCI Pharma
Official Site Inspections
http://www.bci-pharma.com Semrush global rank: 4.63 M Semrush visits lastest month: 2.06 K
- Host name: cluster015.ovh.net
- IP address: 213.186.33.3
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris

More informations about "BCI Pharma"
BCI Pharma - Crunchbase Company Profile & Funding
Mar 12, 2018 BCI Pharma's biology laboratory develops innovative cell-based assays for pharmaceutical research. Lists Featuring This Company. Edit Lists Featuring This Company โฆSee details»
Richter acquires BCI Pharma - Gedeon Richter
Jun 19, 2024 About BCI Pharma The company has been founded in March 2013 by Dominique Surleraux and Dr. Elisabeth Picou. Supported by molecular modelling, BCI designed and โฆSee details»
BCI Pharma Company Profile 2024: Valuation, Investors
BCI Pharma General Information Description. Operator of a biotechnology firm intended to develop an innovative chemo library and medicinal chemistry. The company's firm helps to โฆSee details»
BCI PHARMA - We take care of your health - LinkedIn
BCI Pharma is an innovative bio-pharmaceutical company focused on small molecule drug discovery. We design innovative chemical libraries and our HTS platform can support your โฆSee details»
Richter acquires BCI Pharma - Gedeon Richter
Jun 19, 2024 Specialty pharma transformation ... Gedeon Richter Investors Announcements Richter acquires BCI Pharma. Richter acquires BCI Pharma 19/06/2024 Business related โฆSee details»
BCI Pharma - Products, Competitors, Financials, Employees, โฆ
BCI Pharma is a biopharmaceutical company focused on small molecule drug discovery in the healthcare sector. The company specializes in the development of novel, potent, and selective โฆSee details»
BCI Pharma - BioWin
BCI Pharma. admin January 21, 2021 March 14th, 2023. BCI Pharma is a biotech company which focuses on the discovery and development of novel, highly potent and selective kinase inhibitors. Our aim is to bring new innovative treatments โฆSee details»
BCI Pharma Company Profile - Office Locations, Competitors
BCI Pharma is a biopharmaceutical company focused on small molecule drug discovery. It designs a platform to identify potent and selective kinase inhibitors. The company provides โฆSee details»
Richter acquires BCI Pharma - Gedeon Richter
Jun 19, 2024 About BCI Pharma The company has been founded in March 2013 by Dominique Surleraux and Dr. Elisabeth Picou. Supported by molecular modelling, BCI designed and โฆSee details»
BCI Pharma Company Profile: Overview and Full News Analysis
BCI Pharma, a Liège-based biotechnology company developing innovative kinase inhibitor libraries, received โฌ3.9m in funding . It included โฌ1.9M ($2.2M) in public funding from the โฆSee details»
Company overview & History - BCI PHARMA
The entry of this data is necessary for the processing of the internet userโs request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โฆSee details»
Gedeon Richter buys BCI Pharma - The Pharmaletter
Jul 2, 2024 Hungarian drugmaker Gedeon Richter (RICHT: HB) says it has acquired BCI Pharma, a Belgium-based privately-owned biotech company, carrying out innovative research โฆSee details»
Vision, Value & Strategy โข BCI PHARMA
The entry of this data is necessary for the processing of the internet userโs request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โฆSee details»
BCI Pharma - Contacts, Employees, Board Members, Advisors
BCI Pharma has 2 current employee profiles, including CEO Dominique Surleraux. Contacts. Edit Contacts Section. Job Department. Protected Content. Business Management. Non โฆSee details»
Richter acquires BCI Pharma - FirstWord Pharma
Jun 21, 2024 About BCI Pharma The company has been founded in March 2013 by Dominique Surleraux and Dr. Elisabeth Picou. Supported by molecular modelling, BCI designed and โฆSee details»
BCI-1446 - Drug Targets, Indications, Patents - Synapse - Patsnap
BCI-1446, Initially developed by BCI Pharma SAS, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Nervous System Diseases,Skin and โฆSee details»
News - BCI PHARMA
Jun 21, 2024 The BCI PHARMA Company undertakes to keep this personal data, unless there is a legal or regulatory obligation to the contrary, for a maximum period of three years from the โฆSee details»
Technology - BCI PHARMA
The entry of this data is necessary for the processing of the internet userโs request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โฆSee details»
Pipeline - BCI PHARMA
The entry of this data is necessary for the processing of the internet userโs request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โฆSee details»